昂利康(002940.SZ)：布比卡因获得化学原料药上市申请批准通知书

Core Viewpoint - The company Anglikon (002940.SZ) has received approval from the National Medical Products Administration (NMPA) for the marketing application of its chemical raw material drug, Bupivacaine, which is primarily used for local anesthesia and postoperative analgesia [1] Group 1 - The approval notification was issued by the NMPA, indicating regulatory compliance and readiness for market entry [1] - Bupivacaine is a significant product in the field of anesthesia, enhancing the company's portfolio in the pharmaceutical industry [1]